StockData
CPMDOTCPharmaceutical PreparationsFiscal year ends December 31

CANNAPHARMARX, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026
$0.00+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$1.36M
P/E (TTM)
–
Dividend yield
–

CANNAPHARMARX, INC. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Cannapharmarx does not break out revenue by segment, region or product in the tagged data of its filings for this period type.